Shaojun Ye

767 total citations
42 papers, 548 citations indexed

About

Shaojun Ye is a scholar working on Surgery, Hepatology and Molecular Biology. According to data from OpenAlex, Shaojun Ye has authored 42 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 14 papers in Hepatology and 11 papers in Molecular Biology. Recurrent topics in Shaojun Ye's work include Organ Transplantation Techniques and Outcomes (19 papers), Liver Disease and Transplantation (13 papers) and Renal Transplantation Outcomes and Treatments (10 papers). Shaojun Ye is often cited by papers focused on Organ Transplantation Techniques and Outcomes (19 papers), Liver Disease and Transplantation (13 papers) and Renal Transplantation Outcomes and Treatments (10 papers). Shaojun Ye collaborates with scholars based in China, United States and Germany. Shaojun Ye's co-authors include Qifa Ye, Yanfeng Wang, Zibiao Zhong, Zhongzhong Liu, Yan Xiong, Wei Zhou, Haoyang Xia, Yingzi Ming, Qiuyan Zhang and Cheng Zeng and has published in prestigious journals such as The FASEB Journal, Frontiers in Immunology and American Journal of Transplantation.

In The Last Decade

Shaojun Ye

37 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaojun Ye China 16 196 160 129 92 91 42 548
Brigitta Globke Germany 12 203 1.0× 132 0.8× 148 1.1× 38 0.4× 86 0.9× 42 514
Lawrence Yuen Australia 13 337 1.7× 127 0.8× 70 0.5× 19 0.2× 97 1.1× 51 732
Lin Yan China 16 99 0.5× 84 0.5× 31 0.2× 30 0.3× 54 0.6× 37 473
Hongsi Jiang United States 15 185 0.9× 242 1.5× 31 0.2× 26 0.3× 63 0.7× 43 632
Shinichiro Goto Japan 8 195 1.0× 65 0.4× 241 1.9× 23 0.3× 100 1.1× 30 458
Weitao Que China 12 156 0.8× 80 0.5× 43 0.3× 21 0.2× 35 0.4× 27 342
Jaime L. Hook United States 7 148 0.8× 112 0.7× 11 0.1× 52 0.6× 105 1.2× 12 703
Mohammed Alfaifi Saudi Arabia 11 135 0.7× 149 0.9× 110 0.9× 39 0.4× 107 1.2× 50 508
Michihiro Maruyama Japan 12 245 1.3× 101 0.6× 16 0.1× 29 0.3× 50 0.5× 62 466
J. Li China 11 50 0.3× 159 1.0× 9 0.1× 28 0.3× 29 0.3× 45 481

Countries citing papers authored by Shaojun Ye

Since Specialization
Citations

This map shows the geographic impact of Shaojun Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaojun Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaojun Ye more than expected).

Fields of papers citing papers by Shaojun Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaojun Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaojun Ye. The network helps show where Shaojun Ye may publish in the future.

Co-authorship network of co-authors of Shaojun Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Shaojun Ye. A scholar is included among the top collaborators of Shaojun Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaojun Ye. Shaojun Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zhongzhong, et al.. (2025). Successful Treatment of OXA-23 Acinetobacter baumannii Pneumonia with Sulbactam-Durlobactam in a Liver Transplant Recipient. Infection and Drug Resistance. Volume 18. 5343–5349.
2.
Pan, Liyang, Wei Zhou, Zhongzhong Liu, et al.. (2025). MEF2D Aggravates Hepatic Ischaemia–Reperfusion Injury by Transcriptionally Regulating CXCL1 Through Interacting With NAT10. Liver International. 45(9). e70315–e70315. 1 indexed citations
3.
Zhang, Qiuyan, Sanyun Wu, Wenjin Liang, et al.. (2024). Case report: A successful clinical experience of transplantation of liver and kidney from a donor with myelodysplastic syndromes. Frontiers in Immunology. 15. 1360955–1360955. 1 indexed citations
4.
Liang, Wenjin, Zhongzhong Liu, Shaojun Ye, et al.. (2023). Hypothermic machine perfusion reduces donation after circulatory death liver ischemia–reperfusion injury through the SERPINA3-mediated PI3Kδ/Akt pathway. Human Cell. 37(2). 420–434. 2 indexed citations
5.
Liang, Wenjin, Xiao Huang, Yuxin Xiao, et al.. (2022). Circulating tumour cell combined with DNA methylation for early detection of hepatocellular carcinoma. Frontiers in Genetics. 13. 1065693–1065693. 9 indexed citations
6.
Zhou, Dawei, et al.. (2022). Passenger lymphocyte syndrome after ABO-mismatched kidney transplantation: A case report and literature review. Transplant Immunology. 76. 101725–101725. 2 indexed citations
7.
Kong, Fanhua, Shaojun Ye, Zibiao Zhong, et al.. (2022). Single-Cell Transcriptome Analysis of Chronic Antibody-Mediated Rejection After Renal Transplantation. Frontiers in Immunology. 12. 767618–767618. 30 indexed citations
8.
Zhou, Wei, Zibiao Zhong, Danni Lin, et al.. (2021). Correction: Hypothermic oxygenated perfusion inhibits HECTD3-mediated TRAF3 polyubiquitination to alleviate DCD liver ischemia-reperfusion injury. Cell Death and Disease. 12(6). 1 indexed citations
9.
Ye, Shaojun, Dongjing Liu, Weiyang He, et al.. (2021). Assessment of Donor Liver Pathology Predicts Survival After Liver Transplantation: A Retrospective Cohort Study. Transplantation Proceedings. 53(10). 2963–2970. 2 indexed citations
10.
Zhong, Zibiao, Qiuyan Zhang, Haoyang Xia, et al.. (2020). Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients. American Journal of Transplantation. 20(7). 1916–1921. 87 indexed citations
11.
Wang, Wei, Xiao Hu, Zhiping Xia, et al.. (2020). Mild Hypothermia Attenuates Hepatic Ischemia–Reperfusion Injury through Regulating the JAK2/STAT3-CPT1a-Dependent Fatty Acid β-Oxidation. Oxidative Medicine and Cellular Longevity. 2020. 1–16. 13 indexed citations
12.
Zhou, Wei, Kang Huang, Qiuyan Zhang, et al.. (2020). LINC00844 promotes proliferation and migration of hepatocellular carcinoma by regulating NDRG1 expression. PeerJ. 8. e8394–e8394. 15 indexed citations
13.
Liu, Zhongzhong, Xingjian Zhang, Jun Luo, et al.. (2018). Simvastatin ameliorates total liver ischemia/reperfusion injury via KLF2-mediated mechanism in rats. Clinics and Research in Hepatology and Gastroenterology. 43(2). 171–178. 21 indexed citations
14.
Zhong, Zibiao, Shaojun Ye, Zhongzhong Liu, et al.. (2017). Outcome Improvement for Hypothermic Machine Perfusion Versus Cold Storage for Kidneys From Cardiac Death Donors. Artificial Organs. 41(7). 647–653. 33 indexed citations
15.
Liu, Zhongzhong, Xingjian Zhang, Qi Xiao, et al.. (2017). Pretreatment Donors after Circulatory Death with Simvastatin Alleviates Liver Ischemia Reperfusion Injury through a KLF2‐Dependent Mechanism in Rat. Oxidative Medicine and Cellular Longevity. 2017(1). 3861914–3861914. 24 indexed citations
17.
Ye, Qifa, et al.. (2016). Gypenoside attenuates renal ischemia/reperfusion injury in mice by inhibition of ERK signaling. Experimental and Therapeutic Medicine. 11(4). 1499–1505. 24 indexed citations
18.
Zhong, Zibiao, Shaojun Ye, Yan Xiong, et al.. (2015). Decreased expression of mitochondrial aldehyde dehydrogenase-2 induces liver injury via activation of the mitogen-activated protein kinase pathway. Transplant International. 29(1). 98–107. 20 indexed citations
19.
Ming, Yingzi, Qifa Ye, Mingjie Shao, et al.. (2012). [Clinical analysis of 48 cases of kidney transplantation from cardiac death donors].. PubMed. 37(6). 598–605. 3 indexed citations
20.
Ye, Shaojun. (2007). Living-related Donor Kidney Transplantation:-40 Cases Reports. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026